Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Master's Award: Canada Graduate Scholarships

University of Manitoba

$17,500.00

Efficacy of Blanketrol III and Arctic Sun in cooling non-shivering humans

EF 2020-21

Résumé
This research project is being directed to study the effectiveness of body surface cooling techniques for cooling the core temperature of humans who have experienced a stroke or heart attack. Body surface cooling is a simple and safe technique that involves lowering a person's core temperature by using external devices (cold packs, pads, etc.) on the surface of the skin. This method is used as a treatment for stroke and heart attack patients. Although body surface cooling works, it can be difficult to employ because of shivering (heat production). To prevent shivering, a safe medication called Meperidine (Demerol) is used. Currently, there are two commercial cooling units that are most used: 1) the Blanketrol III with a standard Gel Pad; and 2) the Arctic Sun with specialized pads. A new cooling attachment system has been developed for the Blanketrol III, called the Kool Kit. The new Kool Kit includes a head wrap, and a vest and lower body blanket. The effectiveness of the Kool Kit has not been investigated or compared to the current two systems mentioned above. The purpose of this study is to compare the three commercial cooling units in their ability to decrease core temperature of humans without shivering. The cooling units are: 1) Blanketrol with Gel Pads; 2) Blanketrol with Kool Kit; and 3) an Arctic Sun cooling system. Once cooling has begun, shivering will be inhibited with the injection of Meperidine under the care of a physician. It is predicted that the Blanketrol with Kool Kit will be faster at cooling than the other two systems. The information gathered from this study will contribute to the enhanced care of stroke and heart attack patients by identifying the top cooling system for treatment. It will ensure current care is optimal for patient survival.
Programme
Master's Award: Canada Graduate Scholarships
Emplacement
Manitoba, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
449643
Name
Leclerc Curtis T
Region
Manitoba
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Efficacy of Blanketrol III and Arctic Sun in cooling non-shivering humans
Programtype2
Studentship Programs
Orgnameinp2
University of Manitoba
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Body Surface Cooling; Hypothermia; Myocardial Infarction; Stroke; Therapeutic Hypothermia
Abstract
This research project is being directed to study the effectiveness of body surface cooling techniques for cooling the core temperature of humans who have experienced a stroke or heart attack. Body surface cooling is a simple and safe technique that involves lowering a person's core temperature by using external devices (cold packs, pads, etc.) on the surface of the skin. This method is used as a treatment for stroke and heart attack patients. Although body surface cooling works, it can be difficult to employ because of shivering (heat production). To prevent shivering, a safe medication called Meperidine (Demerol) is used. Currently, there are two commercial cooling units that are most used: 1) the Blanketrol III with a standard Gel Pad; and 2) the Arctic Sun with specialized pads. A new cooling attachment system has been developed for the Blanketrol III, called the Kool Kit. The new Kool Kit includes a head wrap, and a vest and lower body blanket. The effectiveness of the Kool Kit has not been investigated or compared to the current two systems mentioned above. The purpose of this study is to compare the three commercial cooling units in their ability to decrease core temperature of humans without shivering. The cooling units are: 1) Blanketrol with Gel Pads; 2) Blanketrol with Kool Kit; and 3) an Arctic Sun cooling system. Once cooling has begun, shivering will be inhibited with the injection of Meperidine under the care of a physician. It is predicted that the Blanketrol with Kool Kit will be faster at cooling than the other two systems. The information gathered from this study will contribute to the enhanced care of stroke and heart attack patients by identifying the top cooling system for treatment. It will ensure current care is optimal for patient survival.
Competitiondate
202012
Approvedterm2
1 yr 0 mth
Pinamesdelim
Leclerc, Curtis T
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~